PYSZCZYMUKA GREG has filed 26 insider transactions across 2 companies since April 2023.
Most recent transaction: a disposition of 1155 shares of Evoke Pharma Inc ($EVOK) on December 17, 2025.
Activity breakdown: 1 open-market purchase and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 17, 2025 | Evoke Pharma Inc | $EVOK | PYSZCZYMUKA GREG | Not found | D | Stock Option (Right to Buy) | 1155 | $0.00 | 0.0000 | 2,557,408 | 100.00% | 0.05% |
| Dec. 17, 2025 | Evoke Pharma Inc | $EVOK | PYSZCZYMUKA GREG | Not found | D | Stock Option (Right to Buy) | 5833 | $0.00 | 0.0000 | 2,557,408 | 100.00% | 0.23% |
| Oct. 3, 2025 | AYTU BIOPHARMA, INC | $AYTU | PYSZCZYMUKA GREG | Chief Commercial Officer | A | Common Stock | 12500 | $0.00 | 36,102.0000 | 19,476,635 | 52.96% | 0.06% |
| May 21, 2025 | Evoke Pharma Inc | $EVOK | PYSZCZYMUKA GREG | Not found | A | Stock Option (Right to Buy) | 1155 | $0.00 | 6,988.0000 | 1,905,072 | 19.80% | 0.06% |
| March 31, 2025 | AYTU BIOPHARMA, INC | $AYTU | PYSZCZYMUKA GREG | Chief Commercial Officer | M | Common Shares | 209 | $0.00 | 23,602.0000 | 8,782,794 | 0.89% | 0.00% |
| March 31, 2025 | AYTU BIOPHARMA, INC | $AYTU | PYSZCZYMUKA GREG | Chief Commercial Officer | M | Restricted Stock Units | 209 | $0.00 | 0.0000 | 8,782,794 | 100.00% | 0.00% |
| Feb. 20, 2025 | Evoke Pharma Inc | $EVOK | PYSZCZYMUKA GREG | Not found | A | Stock Option (Right to Buy) | 5833 | $0.00 | 5,833.0000 | 1,905,072 | 9999.99% | 0.31% |
| Dec. 31, 2024 | AYTU BIOPHARMA, INC | $AYTU | PYSZCZYMUKA GREG | Chief Commercial Officer | M | Restricted Stock Units | 208 | $0.00 | 209.0000 | 9,099,601 | 49.88% | 0.00% |
| Dec. 31, 2024 | AYTU BIOPHARMA, INC | $AYTU | PYSZCZYMUKA GREG | Chief Commercial Officer | M | Common Shares | 208 | $0.00 | 23,393.0000 | 9,099,601 | 0.90% | 0.00% |
| Nov. 6, 2024 | AYTU BIOPHARMA, INC | $AYTU | PYSZCZYMUKA GREG | Chief Commercial Officer | A | Employee Stock Option (Right to Buy) | 7000 | $0.00 | 7,000.0000 | 9,099,601 | 9999.99% | 0.08% |
| Sept. 30, 2024 | AYTU BIOPHARMA, INC | $AYTU | PYSZCZYMUKA GREG | Chief Commercial Officer | M | Restricted Stock Units | 209 | $0.00 | 417.0000 | 0 | 33.39% | 0.00% |
| Sept. 30, 2024 | AYTU BIOPHARMA, INC | $AYTU | PYSZCZYMUKA GREG | Chief Commercial Officer | M | Common Shares | 209 | $0.00 | 23,185.0000 | 0 | 0.91% | 0.00% |
| June 30, 2024 | AYTU BIOPHARMA, INC | $AYTU | PYSZCZYMUKA GREG | Chief Commercial Officer | M | Restricted Stock Units | 208 | $0.00 | 626.0000 | 0 | 24.94% | 0.00% |
| June 30, 2024 | AYTU BIOPHARMA, INC | $AYTU | PYSZCZYMUKA GREG | Chief Commercial Officer | M | Common Shares | 208 | $0.00 | 22,976.0000 | 0 | 0.91% | 0.00% |
| March 31, 2024 | AYTU BIOPHARMA, INC | $AYTU | PYSZCZYMUKA GREG | Chief Commercial Officer | M | Common Shares | 208 | $0.00 | 22,768.0000 | 0 | 0.92% | 0.00% |
| March 31, 2024 | AYTU BIOPHARMA, INC | $AYTU | PYSZCZYMUKA GREG | Chief Commercial Officer | M | Restricted Stock Units | 208 | $0.00 | 834.0000 | 0 | 19.96% | 0.00% |
| Dec. 31, 2023 | AYTU BIOPHARMA, INC | $AYTU | PYSZCZYMUKA GREG | Chief Commercial Officer | M | Common Shares | 209 | $0.00 | 22,560.0000 | 0 | 0.94% | 0.00% |
| Dec. 31, 2023 | AYTU BIOPHARMA, INC | $AYTU | PYSZCZYMUKA GREG | Chief Commercial Officer | M | Restricted Stock Units | 209 | $0.00 | 1,042.0000 | 0 | 16.71% | 0.00% |
| Sept. 30, 2023 | AYTU BIOPHARMA, INC | $AYTU | PYSZCZYMUKA GREG | Chief Commercial Officer | M | Common Shares | 208 | $0.00 | 22,351.0000 | 0 | 0.94% | 0.00% |
| Sept. 30, 2023 | AYTU BIOPHARMA, INC | $AYTU | PYSZCZYMUKA GREG | Chief Commercial Officer | M | Restricted Stock Units | 208 | $0.00 | 1,251.0000 | 0 | 14.26% | 0.00% |
| Aug. 11, 2023 | AYTU BIOPHARMA, INC | $AYTU | PYSZCZYMUKA GREG | Chief Commercial Officer | A | Employee Stock Option (Right to Buy) | 7000 | $0.00 | 7,000.0000 | 0 | 9999.99% | 0.00% |
| June 30, 2023 | AYTU BIOPHARMA, INC | $AYTU | PYSZCZYMUKA GREG | Chief Commerical Officer | M | Restricted Stock Units | 208 | $0.00 | 1,459.0000 | 0 | 12.48% | 0.00% |
| June 30, 2023 | AYTU BIOPHARMA, INC | $AYTU | PYSZCZYMUKA GREG | Chief Commerical Officer | M | Common Shares | 208 | $0.00 | 22,143.0000 | 0 | 0.95% | 0.00% |
| June 16, 2023 | AYTU BIOPHARMA, INC | $AYTU | PYSZCZYMUKA GREG | Chief Commerical Officer | P | Common Shares | 12000 | $1.87 | 21,935.0000 | 0 | 120.79% | 0.00% |
| April 25, 2023 | AYTU BIOPHARMA, INC | $AYTU | PYSZCZYMUKA GREG | Chief Commerical Officer | M | Common Shares | 833 | $0.00 | 9,935.0000 | 0 | 9.15% | 0.00% |
| April 25, 2023 | AYTU BIOPHARMA, INC | $AYTU | PYSZCZYMUKA GREG | Chief Commerical Officer | M | Restricted Stock Units | 833 | $0.00 | 1,667.0000 | 0 | 33.32% | 0.00% |